Drug or treatment

Baricitinib clinical trials

• 18Clinical trials
• 34Countries

Newest trials

All recruiting trials (18)

• Safety and drug level study of multiple doses of upadacitinib, tofacitinib, and baricitinib in healthy adults

  This early-phase study tests how different doses of upadacitinib, tofacitinib, and baricitinib behave in healthy adults to understand safety and how the drugs act in the body.

  Recruiting Phase 1 AbbVie · Grayslake, Illinois · NCT07843693

• Baricitinib for persistent low platelets after stem cell transplant

  We’re testing baricitinib to see if it can help people with long-term low platelets after an allogeneic stem cell transplant who didn’t respond to other treatments.

  Recruiting Phase 1/2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT07535645

• Telitacicept plus baricitinib for refractory rheumatoid arthritis

  This test tries combining telitacicept with baricitinib to see if it helps adults with refractory rheumatoid arthritis who haven't improved on other treatments.

  Recruiting Zhejiang Provincial People's Hospital · Hangzhou, Zhejiang · NCT07491016

• Baricitinib Added to Corticosteroids in PMR (Polymyalgia Rheumatica) May Improve Control

  This study tests whether baricitinib plus low-dose steroids works better than steroids alone for people 50 and older with PMR.

  Recruiting at 19 sites Phase 3 University Hospital, Brest · Aix-en-Provence and 22 other locations · NCT07279688

• Baricitinib for people with STAT3‑related Hyper‑IgE (Job) syndrome who have lupus-like disease or atopic dermatitis

  This trial will test whether the JAK inhibitor baricitinib can be taken safely and may reduce lupus-like symptoms or severe eczema in people aged 12 and older with STAT3-related Hyper‑IgE (Job) syndrome.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07262983

• Baricitinib to preserve insulin-producing beta cells in people newly diagnosed with type 1 diabetes

  This trial will test whether the drug baricitinib can help preserve insulin-producing beta cells in children and adults who were recently diagnosed with type 1 diabetes.

  Recruiting at 108 sites Phase 3 Eli Lilly and Company · Aurora, Colorado and 129 other locations · NCT07222332

• Baricitinib to delay the start of clinical (Stage 3) type 1 diabetes in at‑risk children and adults

  This will test whether the medicine baricitinib can delay the start of clinical type 1 diabetes in children and adults who are at high risk.

  Recruiting at 95 sites Phase 3 Eli Lilly and Company · Santa Barbara, California and 111 other locations · NCT07222137

• Nerve conduction testing for people with rheumatoid arthritis taking baricitinib

  This project will test whether nerve conduction testing detects peripheral nerve changes in adults with rheumatoid arthritis who are taking baricitinib.

  Recruiting Sohag University · Sohag · NCT06977035

• Evaluating Baricitinib for Skin Tightening in Systemic Sclerosis

  This study is testing if a new medication called baricitinib can help improve skin tightness in people with diffuse cutaneous systemic sclerosis compared to a standard treatment.

  Recruiting Phase 3 Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh · Dhaka · NCT06936215

• Using baricitinib to treat Kohlmeier-Degos disease with neurological symptoms

  This study is testing if the medication baricitinib can help adults with Kohlmeier-Degos disease who have neurological symptoms feel better over 24 weeks.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06923072

• Using Baricitinib to treat intestinal Behçet's Syndrome

  This study is testing if the medication Baricitinib can help people with tough cases of intestinal Behçet's Syndrome just as well as the current treatment, Adalimumab.

  Recruiting Phase 2 Peking Union Medical College Hospital · Beijing, Beijing Municipality and 1 other locations · NCT06849908

• New treatment for generalized vitiligo using JAK inhibitors

  This study is testing if a new medication called baricitinib, combined with light therapy, can help people with active generalized vitiligo regain skin color and improve their quality of life.

  Recruiting Phase 2/3 South Valley University · Qina · NCT06768840

• Evaluating Baricitinib for Long COVID Symptoms

  This study is testing if the medication baricitinib can help adults with Long COVID feel better physically and mentally compared to a placebo.

  Recruiting at 17 sites Phase 3 Vanderbilt University Medical Center · Tucson, Arizona and 16 other locations · NCT06631287

• Baricitinib for moderate-to-severe intracerebral bleeding and contusions after head injury

  This will test whether giving baricitinib soon after a head injury helps adults with moderate to severe brain bleeding or contusions recover better.

  Recruiting Phase 2 Tang-Du Hospital · Xi'an, Shaanxi · NCT06065046

• Treatment of severe alopecia areata in children using baricitinib

  This study is testing if the medication baricitinib can help children aged 6 to under 18 with severe alopecia areata by seeing how well it works and if it’s safe over a long period.

  Recruiting at 99 sites Phase 3 Eli Lilly and Company · Birmingham, Alabama and 126 other locations · NCT05723198

• Using Baricitinib to Target HIV in the Central Nervous System

  This study is testing if the medication baricitinib can help reduce HIV in the brain for people living with HIV who are already on stable treatment.

  Recruiting at 2 sites Phase 2 Emory University · Atlanta, Georgia and 1 other locations · NCT05452564

• Using baricitinib to treat patients with dermatomyositis

  This study is testing if the medication baricitinib can help people with dermatomyositis improve while reducing their need for steroids.

  Recruiting Phase 3 Assistance Publique - Hôpitaux de Paris · Paris · NCT04972760

• Evaluating baricitinib for treating juvenile idiopathic arthritis in children

  This study tests if continuing treatment with baricitinib helps children with juvenile idiopathic arthritis feel better and stay safe.

  Recruiting at 46 sites Phase 3 Eli Lilly and Company · Rosario and 76 other locations · NCT03773965

Quick answers

How many clinical trials of Baricitinib are recruiting right now?

18, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 34 countries. The most sites are in United States (8 trials), France (6 trials), China (5 trials), Australia (4 trials), Germany (4 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 8, Phase 2: 4, Phase 1: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →